ATENOLOL

Course overview

ATENOLOL IS A SECOND-GENERATION BETA-1-SELECTIVE ADRENERGIC ANTAGONIST THAT REDUCES HEART RATE AND BLOOD PRESSURE AND DECREASES MYOCARDIAL CONTRACTILITY. IT IS FDA-APPROVED AND INDICATED IN TREATING HYPERTENSION, ANGINA PECTORIS, AND ACUTE MYOCARDIAL INFARCTION. NON-FDA-APPROVED INDICATIONS INCLUDE TREATMENT OF ARRHYTHMIAS, MIGRAINE PROPHYLAXIS, PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA, ALCOHOL WITHDRAWAL, THYROTOXICOSIS, AND PROPHYLAXIS AGAINST SECONDARY MYOCARDIAL INFARCTION. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, SAFE ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF ATENOLOL. IT ALSO HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN MANAGING PATIENTS USING ATENOLOL.